Cargando…

Comparison of antimicrobial resistances and clinical features in community-onset Escherichia coli and Klebsiella pneumoniae bacteremia

BACKGROUND/AIMS: The aim of this study was to compare antimicrobial resistance, clinical features, and outcomes of community-onset Escherichia coli (COEC) and Klebsiella pneumoniae (COKP) bacteremia. METHODS: The medical records of patients diagnosed with E. coli or K. pneumoniae bacteremia in the e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sung, Hwa Seok, Lee, Je Won, Bae, Sohyun, Kwon, Ki Tae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969070/ https://www.ncbi.nlm.nih.gov/pubmed/32229796 http://dx.doi.org/10.3904/kjim.2019.272

Ejemplares similares

Third-generation cephalosporin resistance of community-onset Escherichia coli and Klebsiella pneumoniae bacteremia in a secondary hospital
por: Lee, Shinwon, et al.
Publicado: (2014)

Risk Factors for Mortality in Patients with Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae and Escherichia coli bacteremia
por: Seo, Hyeonji, et al.
Publicado: (2021)

Impact of Empiric Antimicrobial Therapy on Outcomes in Patients with Escherichia coli and Klebsiella pneumoniae Bacteremia: A Cohort Study
por: Thom, Kerri A, et al.
Publicado: (2008)

Propensity score matched analysis comparing the clinical outcome of Klebsiella pneumoniae and Escherichia coli causing community-onset monomicrobial bacteremia
por: Kuo, Tsung-Hang, et al.
Publicado: (2017)

Clinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae
por: Chaubey, Vikas P, et al.
Publicado: (2010)

2261. Impact of Antimicrobial Stewardship Program on Klebsiella pneumoniae and Escherichia coli Antimicrobial Resistance
por: Ferreiro, Jose Luis Lamas, et al.
Publicado: (2023)

Global forecast of antimicrobial resistance in invasive isolates of Escherichia coli and Klebsiella pneumoniae
por: Alvarez-Uria, Gerardo, et al.
Publicado: (2018)

No association between resistance mutations, empiric antibiotic, and mortality in ceftriaxone-resistant Escherichia coli and Klebsiella pneumoniae bacteremia
por: Heng, Shi Thong, et al.
Publicado: (2018)

Transfer of antimicrobial resistance plasmids from Klebsiella pneumoniae to Escherichia coli in the mouse intestine
por: Schjørring, Susanne, et al.
Publicado: (2008)

Community-Acquired versus Nosocomial Klebsiella pneumoniae Bacteremia: Clinical Features, Treatment Outcomes, and Clinical Implication of Antimicrobial Resistance
por: Kang, Cheol-In, et al.
Publicado: (2006)

Risk Factors and Molecular Epidemiology of Community-Onset Extended-Spectrum β-Lactamase-Producing Escherichia coli Bacteremia
por: Park, Yoon Soo, et al.
Publicado: (2014)

Definitive Cefazolin Therapy for Stabilized Adults with Community-Onset Escherichia coli, Klebsiella Species, and Proteus mirabilis Bacteremia: MIC Matters
por: Hsieh, Chih-Chia, et al.
Publicado: (2020)

Effect of rapid cefpodoxime disk screening for early detection of third-generation cephalosporin resistance in Escherichia coli and Klebsiella pneumoniae bacteremia
por: Sakai, Mikiyasu, et al.
Publicado: (2023)

European Committee on Antimicrobial Susceptibility Testing-Recommended Rapid Antimicrobial Susceptibility Testing of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus From Positive Blood Culture Bottles
por: Park, Jong-Min, et al.
Publicado: (2023)

1605. Differences in Clinical Characteristics of Third Generation Cephalosporin Resistance and Treatment Outcomes in Escherichia coli and Klebsiella pneumoniae Bacteremia in Patients with Liver Cirrhosis
por: Ham, Sin Young, et al.
Publicado: (2020)

MCR1 and KPC2 Co-producing Klebsiella pneumoniae Bacteremia: First Case in Korea
por: Park, Ji Young, et al.
Publicado: (2019)

Minimal impact of selective susceptibility reporting on the use of piperacillin-tazobactam for Escherichia coli and Klebsiella bacteremia
por: Zahlanie, Yorgo, et al.
Publicado: (2021)

Klebsiella pneumoniae Bacteremia and Capsular Serotypes, Taiwan
por: Liao, Chun-Hsing, et al.
Publicado: (2011)

Recurrent Klebsiella pneumoniae Bacteremia Due to Endotipsitis
por: Everett, Scott, et al.
Publicado: (2023)

Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data
por: Stoesser, N., et al.
Publicado: (2013)

To the editor:: Community-acquired versus Nosocomial Klebsiella pneumonia Bacteremia: Clinical Features, Treatment Outcomes, and Clinical Implication of Antimicrobial Resistance
por: Vandijck, Dominique M, et al.
Publicado: (2007)

1508. Carbapenem vs. Non-carbapenem as Empiric Regimens for Bacteremia Caused by ESBL Producing Escherichia coli and Klebsiella pneumoniae in Children: Preliminary Study
por: Park, Saera, et al.
Publicado: (2019)

1061. Decreased Utilization of Piperacillin–Tazobactam for Escherichia coli and Klebsiella Bacteremia due to Selective Susceptibility Reporting
por: Zahlanie, Yorgo, et al.
Publicado: (2019)

Antimicrobial susceptibility profiles of Escherichia coli and Klebsiella pneumoniae isolated from outpatients in urban and rural districts of Uganda
por: Najjuka, Christine F., et al.
Publicado: (2016)

Resveratrol enhances the antimicrobial effect of polymyxin B on Klebsiella pneumoniae and Escherichia coli isolates with polymyxin B resistance
por: Liu, Li, et al.
Publicado: (2020)

Comparison of Escherichia coli and Klebsiella pneumoniae Acute Pyelonephritis in Korean Patients
por: Hyun, Miri, et al.
Publicado: (2019)

ESBL‐production in Escherichia coli and Klebsiella pneumoniae isolates from Nigeria
por: Hertz, Frederik B., et al.
Publicado: (2019)

Rapid Detection of Piperacillin-Tazobactam Resistance in Klebsiella pneumoniae and Escherichia coli
por: Ortiz de la Rosa, José Manuel, et al.
Publicado: (2023)

Atypical SARS and Escherichia coli Bacteremia
por: Tan, Thuan Tong, et al.
Publicado: (2004)

Multidrug-Resistant Escherichia coli Bacteremia
por: Alhashash, Fahad, et al.
Publicado: (2013)

Prevalence and antimicrobial susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital
por: Kader, Abdulrahman Abdulla, et al.
Publicado: (2005)

Antimicrobial resistance of Escherichia coli, Enterobacter spp., Klebsiella pneumoniae and Enterococcus spp. isolated from the feces of giant panda
por: Wang, Xin, et al.
Publicado: (2022)

New Delhi Metallo-β-Lactamase in Klebsiella pneumoniae and Escherichia coli, Canada
por: Mulvey, Michael R., et al.
Publicado: (2011)

Genomic epidemiology of global Klebsiella pneumoniae carbapenemase (KPC)-producing Escherichia coli
por: Stoesser, N., et al.
Publicado: (2017)

Antibiotic Consumption in Hospitals and Resistance Rate of Klebsiella pneumoniae and Escherichia coli in Montenegro
por: Mijović, Gordana, et al.
Publicado: (2020)

Frequency of Beta-Lactamase Antibiotic Resistance Genes in Escherichia Coli and Klebsiella pneumoniae
por: Golsha, Roghieh, et al.
Publicado: (2021)

Colistin resistance in Escherichia coli and Klebsiella pneumoniae in humans and backyard animals in Ecuador
por: Bastidas-Caldes, Carlos, et al.
Publicado: (2023)

Purpura Fulminans in the Setting of Klebsiella Pneumoniae Bacteremia and Acetaminophen Overdose
por: Nguyen, Vincent, et al.
Publicado: (2020)

A Simple Scoring Algorithm That Predicts Abscesses in Adults with Community-Onset Klebsiella pneumoniae Bacteremia: Hypermucoviscosity Matters
por: Hong, Ming-Yuan, et al.
Publicado: (2020)

Clinical Impact of Sequence Type 131 in Adults with Community-Onset Monomicrobial Escherichia Coli Bacteremia
por: Wang, Jiun-Ling, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nuv99a2bg4mdmspevbrnnqajch